Healthcare Professionals

Active Clinical Studies

Accuray Incorporated is committed to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. We strive to achieve this goal by supporting well designed clinical research in a variety of pathology specific applications.

Accuray is sponsoring several clinical studies that are currently enrolling patients; these are listed below. Click on the National Institute of Health links for complete information on each study. To contact Accuray to learn more about participating as a patient or as a clinician in any of our open clinical studies, click the e-mail link below for the appropriate study or call +1.408.789.4301 or toll free +1.888.522.3740 x4301.

There are a number of active clinical studies for both the CyberKnife and TomoTherapy Systems. To view a complete list, click here.

Prostate

The PACE Study: A randomized study comparing surgery, CyberKnife and conventional radiation therapy for early stage prostate cancer
National Institute of Health (identifier: NCT01584258)
To visit the website click here.
To email someone about this study click here.

Liver

A randomized study treating patients with primary liver cancer (hepatocellular carcinoma) with the CyberKnife System
National Institute of Health (identifier: NCT01318447)
To visit the website click here.
To email someone about this study click here.

  

Lung

Treating inoperable early stage lung cancer with the CyberKnife System
National Institute of Health (identifier: NCT00643318)
To visit the website click here.
To email someone about this study click here.

A randomized study comparing surgery to CyberKnife for operable Stage I lung cancer
National Institute of Health (identifier: NCT00840749)
To visit the website click here.
To email someone about this study click here.